processing
285 results
1 - 100- antipsychotics
- central nervous system stimulants
- aurothioglucose
- auranofin
- anti alzheimers agents
- gold sodium thiomalate
- flupentixol
- zuclopenthixol
- fluPHENAZine
- laxatives
- molindone
- perphenazine
- thioridazine
- anticonvulsants
- antidiarrheals
- antirheumatics
- immunosuppressants
- ivacaftor
- antiarrhythmics
- antiretrovirals
- antituberculars
- diuretics
- antianxiety agents
- antiasthmatics
- antidepressants
- antihypertensives
- antipyretics
- antiulcer agents
- natural/herbal products
- trifluoperazine
- amcinonide
- clobetasol
- clocortolone
- desonide
- diflorasone
- halcinonide
- HYDROXYprogesterone caproate
- antianginals
- anticoagulants
- antifungals
- antihistamines
- anti infectives
- antivirals
- bronchodilators
- corticosteroids
- hormones
- lipid lowering agents
- sedative hypnotics
- thrombolytics
- fluocinolone
- fluocinonide
- flurandrenolide
- glatiramer
- prednicarbate
- tacrine
- thiothixene
- promazine
- raxibacumab
- lumateperone
- beta blockers
- bone resorption inhibitors
- vaccines immunizing agents
- vascular headache suppressants
- vitamins
- minerals/electrolytes/ph modifiers
- vitamin B complex with vitamin C
- alclometasone (topical)
- desoximetasone
- dexamethasone (topical)
- halobetasol
- hydrocortisone (topical)
- mometasone (topical)
- triamcinolone (topical)
- alfalfa
- antiparkinson agents
- antiplatelet agents
- fluticasone (topical)
- antianemics
- antineoplastics
- nonopioid analgesics
- betamethasone (topical)
- tipranavir
- calcium channel blockers
- mesoridazine
- ruxolitinib
- opioid analgesics
- letermovir
- beractant
- verteporfin
- alpha1-proteinase inhibitor, human
- Differences in U.S. and Canadian Pharmaceutical Practices
- lyme disease vaccine (recombinant OspA)
- nonsteroidal anti inflammatory drugs nsaids
- kava-kava
- trace metal combination additive
- cetuximab
- sarilumab
- vitamin A
- ruxolitinib (topical)